BALOXAVIR MARBOXIL (Xofluza®)
Clinical Indication
Treatment and post exposure prophylaxis of influenza
Date of classification
April 2022
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.